Tag: CSE:LOVE

April 20, 2020

Cannara Harvests First Crop on 420

Cannara Biotech Inc. (CSE:LOVE, OTCQB:LOVFF, FRA:8CB) announced the first successful harvest from one of Canada's largest indoor facilities, located in...
April 16, 2020

Cannara Biotech Inc. Reports Q2 2020 Financial Results

Cannara Biotech Inc. (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB) announced financial results for the three and six-month periods ended February 29, 2020.
February 20, 2020

Cannara Insiders Form Buying Group to Fully Acquire FSD/FV Pharma’s Position in Cannara

Insiders' increase stake in Cannara coincides as cultivation poised to commence
February 20, 2020

FSD Pharma Generates $7.7 Million in Proceeds and 670 Percent Return on Investment through Sale of Interest in Cannara Biotech

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A) today announced the sale of its 12% equity interest in Cannara Biotech Inc.
February 3, 2020

Cannara Biotech’s Farnham Facility Receives Cultivation Licence

Cannara Biotech Inc. announced the receipt of its cultivation licence from Health Canada for Phase 1 of its purpose-built Farnham...
January 20, 2020

Cannara Biotech Reports Q1 2020 Financial Results

Cannara Biotech Inc. (CSE:LOVE, OTCQB:LOVFF, FRA:8CB) announced financial results for the three-month period ended November 30, 2019.
November 27, 2019

Cannara Biotech Reports Q4 and Year-End 2019 Financial Results

Cannara Biotech Inc. (CSE:LOVE, FRA:8CB, OTCQB:LOVFF) announced financial results for the three month period and year ended August 31, 2019.